688314 康拓医疗
已收盘 12-12 15:00:00
资讯
新帖
简况
每周股票复盘：康拓医疗（688314）PEEK材料产品推动业绩增长
证券之星 · 11-09
每周股票复盘：康拓医疗（688314）PEEK材料产品推动业绩增长
股市必读：康拓医疗（688314）11月4日披露最新机构调研信息
证券之星 · 11-05
股市必读：康拓医疗（688314）11月4日披露最新机构调研信息
康拓医疗：11月4日召开业绩说明会
证券之星 · 11-04
康拓医疗：11月4日召开业绩说明会
每周股票复盘：康拓医疗（688314）股东户数增15.3%，Q3净利降22.22%
证券之星 · 11-02
每周股票复盘：康拓医疗（688314）股东户数增15.3%，Q3净利降22.22%
康拓医疗（688314）2025年三季报简析：营收净利润同比双双增长
证券之星 · 10-29
康拓医疗（688314）2025年三季报简析：营收净利润同比双双增长
图解康拓医疗三季报：第三季度单季净利润同比下降22.22%
证券之星 · 10-27
图解康拓医疗三季报：第三季度单季净利润同比下降22.22%
康拓医疗(688314)9月30日股东户数0.59万户，较上期增加15.3%
证券之星 · 10-27
康拓医疗(688314)9月30日股东户数0.59万户，较上期增加15.3%
每周股票复盘：康拓医疗（688314）美国子公司大幅减亏
证券之星 · 09-21
每周股票复盘：康拓医疗（688314）美国子公司大幅减亏
股市必读：康拓医疗（688314）9月17日披露最新机构调研信息
证券之星 · 09-18
股市必读：康拓医疗（688314）9月17日披露最新机构调研信息
康拓医疗：9月17日召开业绩说明会
证券之星 · 09-17
康拓医疗：9月17日召开业绩说明会
康拓医疗（688314）披露公司2025年半年度利润分配预案，9月16日股价上涨1.32%
证券之星 · 09-16
康拓医疗（688314）披露公司2025年半年度利润分配预案，9月16日股价上涨1.32%
每周股票复盘：康拓医疗（688314）拟每10股派2元
证券之星 · 09-07
每周股票复盘：康拓医疗（688314）拟每10股派2元
股市必读：康拓医疗（688314）9月1日披露最新机构调研信息
证券之星 · 09-02
股市必读：康拓医疗（688314）9月1日披露最新机构调研信息
每周股票复盘：康拓医疗（688314）股东户数增14.97%，中报净利增12.72%
证券之星 · 08-31
每周股票复盘：康拓医疗（688314）股东户数增14.97%，中报净利增12.72%
康拓医疗（688314）2025年中报简析：营收净利润同比双双增长
证券之星 · 08-30
康拓医疗（688314）2025年中报简析：营收净利润同比双双增长
图解康拓医疗中报：第二季度单季净利润同比增长7.25%
证券之星 · 08-28
图解康拓医疗中报：第二季度单季净利润同比增长7.25%
康拓医疗(688314)6月30日股东户数0.51万户，较上期增加14.97%
证券之星 · 08-28
康拓医疗(688314)6月30日股东户数0.51万户，较上期增加14.97%
康拓医疗涨5.05% 政策催化与资金回流推动上涨
智选洞察 · 08-11
康拓医疗涨5.05% 政策催化与资金回流推动上涨
医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道
国金证券 · 08-10
医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道
牙科医疗概念盘中拉升，乐普医疗涨9.97%
市场透视 · 08-08
牙科医疗概念盘中拉升，乐普医疗涨9.97%
暂无数据
公司概况
公司名称：
西安康拓医疗技术股份有限公司
所属行业：
专用设备制造业
上市日期：
2021-05-18
主营业务：
西安康拓医疗技术股份有限公司的主营业务是三类植入医疗器械产品研发、生产、销售。公司的主要产品是PEEK材料产品、钛材料产品、可吸收产品、脑引流装置、修补类产品、口腔种植、工具类。
发行价格：
17.34
{"stockData":{"symbol":"688314","market":"SH","secType":"STK","nameCN":"康拓医疗","latestPrice":31.63,"timestamp":1765522800000,"preClose":31.62,"halted":0,"volume":421068,"delay":0,"changeRate":0.0003,"floatShares":81239200,"shares":81239200,"eps":1.0882,"marketStatus":"已收盘","change":0.01,"latestTime":"12-12 15:00:00","open":31.62,"high":31.95,"low":31.38,"amount":13332800,"amplitude":0.018,"askPrice":31.65,"askSize":2,"bidPrice":31.63,"bidSize":50,"shortable":0,"etf":0,"ttmEps":1.0882,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":31.62,"symbolType":"stock_kcb","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":34.78,"lowLimit":28.46,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":81239172,"isCdr":false,"pbRate":3.73,"roa":"--","peRate":29.066348,"roe":"12.16%","epsLYR":1.09,"committee":0.206897,"marketValue":2570000000,"turnoverRate":0.0052,"status":0,"afterMarket":{"amount":0,"volume":0,"close":31.63,"buyVolume":0,"sellVolume":0,"time":1765524837768,"indexStatus":"已收盘 12-12 15:30:00","preClose":31.62},"floatMarketCap":2570000000},"requestUrl":"/m/hq/s/688314/tweets","defaultTab":"tweets","newsList":[{"id":"2582644618","title":"每周股票复盘：康拓医疗（688314）PEEK材料产品推动业绩增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2582644618","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582644618?lang=zh_cn&edition=full","pubTime":"2025-11-09 05:20","pubTimestamp":1762636827,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，康拓医疗报收于33.7元，较上周的33.73元下跌0.09%。本周，康拓医疗11月3日盘中最高价报33.93元。公司库存同比增长主要因第三季度采购PEEK原材料较同期增加较多所致，不存在减值风险；经营活动产生的现金流量净额同比下降主要因购买原料货款增加及费用支付现金流增加所致。随着神经外科类集采的深入执行，公司核心产品PEEK材料颅骨修补固定类产品渗透率持续提升，也是公司业绩增长的主要动力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688314"],"gpt_icon":0},{"id":"2581765678","title":"股市必读：康拓医疗（688314）11月4日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2581765678","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581765678?lang=zh_cn&edition=full","pubTime":"2025-11-05 04:04","pubTimestamp":1762286657,"startTime":"0","endTime":"0","summary":"截至2025年11月4日收盘，康拓医疗报收于33.43元，下跌0.89%，换手率0.84%，成交量6852.0手，成交额2282.96万元。当日关注点来自交易信息汇总：11月4日主力资金净流出119.08万元，占总成交额5.22%。来自机构调研要点：公司Q3营收下降主要受神经外科类集采续约延期影响，未来随集采落地及PEEK产品放量，收入增速有望恢复。来自机构调研要点：交联透明质酸钠凝胶已提交注册申请并完成体系审核，无线颅内压检测仪注册工作正在进行中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500003055.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688314"],"gpt_icon":0},{"id":"2580787832","title":"康拓医疗：11月4日召开业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2580787832","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580787832?lang=zh_cn&edition=full","pubTime":"2025-11-04 19:03","pubTimestamp":1762254202,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年11月4日康拓医疗发布公告称公司于2025年11月4日召开业绩说明会。市场对于公司在新业务上的故事已经听了很多，但目前这些业务对业绩的贡献仍然有限。未来公司将根据发展战略和各业务布局需求，在确保财务资金风险可控、产业协同效应显著以及管理体系融合顺畅的前提下，积极开展投资类活动，拓展产品管线和业务渠道，为公司的可持续发展注入外生动力。康拓医疗主营业务：三类植入医疗器械产品研发、生产、销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400032943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688314"],"gpt_icon":0},{"id":"2580785408","title":"每周股票复盘：康拓医疗（688314）股东户数增15.3%，Q3净利降22.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580785408","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580785408?lang=zh_cn&edition=full","pubTime":"2025-11-02 09:12","pubTimestamp":1762045933,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，康拓医疗报收于33.73元，较上周的35.27元下跌4.37%。本周，康拓医疗10月27日盘中最高价报35.53元。股本股东变化截至2025年9月30日，康拓医疗股东户数为5879户，较6月30日增加780户，增幅15.3%。业绩披露要点康拓医疗2025年三季报显示，公司主营收入2.51亿元，同比上升4.57%；归母净利润7671.52万元，同比持平；扣非净利润7160.75万元，同比增长7.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200002032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688314"],"gpt_icon":0},{"id":"2579521915","title":"康拓医疗（688314）2025年三季报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2579521915","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579521915?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:18","pubTimestamp":1761689901,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期康拓医疗发布2025年三季报。根据财报显示，康拓医疗营收净利润同比双双增长。截至本报告期末，公司营业总收入2.51亿元，同比上升4.57%，归母净利润7671.52万元，同比上升0.0%。按单季度数据看，第三季度营业总收入8077.24万元，同比下降6.92%，第三季度归母净利润2171.65万元，同比下降22.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900008875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688314"],"gpt_icon":0},{"id":"2578179406","title":"图解康拓医疗三季报：第三季度单季净利润同比下降22.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578179406","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578179406?lang=zh_cn&edition=full","pubTime":"2025-10-27 18:44","pubTimestamp":1761561872,"startTime":"0","endTime":"0","summary":"证券之星消息，康拓医疗2025年三季报显示，公司主营收入2.51亿元，同比上升4.57%；归母净利润7671.52万元，同比上升0.0%；扣非净利润7160.75万元，同比上升7.8%；其中2025年第三季度，公司单季度主营收入8077.24万元，同比下降6.92%；单季度归母净利润2171.65万元，同比下降22.22%；单季度扣非净利润2122.02万元，同比下降18.77%；负债率12.72%，投资收益-863.3万元，财务费用-26.99万元，毛利率78.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700029043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688314"],"gpt_icon":0},{"id":"2578667616","title":"康拓医疗(688314)9月30日股东户数0.59万户，较上期增加15.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578667616","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578667616?lang=zh_cn&edition=full","pubTime":"2025-10-27 17:10","pubTimestamp":1761556207,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康拓医疗披露，截至2025年9月30日公司股东户数为5879.0户，较6月30日增加780.0户，增幅为15.3%。在医疗器械行业个股中，康拓医疗股东户数低于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.14万户。从股价来看，2025年6月30日至2025年9月30日，康拓医疗区间涨幅为17.13%，在此期间股东户数增加780.0户，增幅为15.3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700023063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688314"],"gpt_icon":0},{"id":"2569245777","title":"每周股票复盘：康拓医疗（688314）美国子公司大幅减亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2569245777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569245777?lang=zh_cn&edition=full","pubTime":"2025-09-21 03:42","pubTimestamp":1758397335,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，康拓医疗报收于36.12元，较上周的37.85元下跌4.57%。本周，康拓医疗9月16日盘中最高价报38.27元。公司公告汇总西安康拓医疗技术股份有限公司于2025年9月16日召开2025年第二次临时股东会，会议由董事会召集，现场会议在西安市高新区毕原一路西段1451号公司三楼会议室举行，网络投票通过上海证券交易所系统进行。表决结果显示，两项议案同意比例分别为99.8793%和99.7848%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100000862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688314","BK0251"],"gpt_icon":0},{"id":"2568411429","title":"股市必读：康拓医疗（688314）9月17日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2568411429","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568411429?lang=zh_cn&edition=full","pubTime":"2025-09-18 03:52","pubTimestamp":1758138735,"startTime":"0","endTime":"0","summary":"截至2025年9月17日收盘，康拓医疗报收于37.14元，下跌1.54%，换手率1.43%，成交量1.16万手，成交额4338.6万元。出席本次股东会的股东及代理人共52人，代表股份52,923,358股，占公司有表决权股份总数的65.1451%。表决结果显示，两项议案同意比例分别为99.8793%和99.7848%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091800002888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688314","BK0251"],"gpt_icon":0},{"id":"2568493394","title":"康拓医疗：9月17日召开业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2568493394","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568493394?lang=zh_cn&edition=full","pubTime":"2025-09-17 19:33","pubTimestamp":1758108786,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年9月17日康拓医疗发布公告称公司于2025年9月17日召开业绩说明会。公司一方面通过实施积极的营销政策，提高PEEK材料产品的收入规模，另一方面通过拓宽产品品类，提升非集采区域高值产品的收入规模，以及通过持续优化生产流程，降低生产成本，以维持公司毛利率的稳定。康拓医疗主营业务：三类植入医疗器械产品研发、生产、销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700035561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688314"],"gpt_icon":0},{"id":"2567848989","title":"康拓医疗（688314）披露公司2025年半年度利润分配预案，9月16日股价上涨1.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567848989","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567848989?lang=zh_cn&edition=full","pubTime":"2025-09-16 22:49","pubTimestamp":1758034159,"startTime":"0","endTime":"0","summary":"截至2025年9月16日收盘，康拓医疗报收于37.72元，较前一交易日上涨1.32%，最新总市值为30.64亿元。该股当日开盘37.31元，最高38.27元，最低37.2元，成交额达3900.92万元，换手率为1.27%。根据近日发布的《西安康拓医疗技术股份有限公司2025年第二次临时股东会决议公告》，康拓医疗于2025年9月16日召开2025年第二次临时股东会，会议审议通过了《关于公司2025年半年度利润分配预案的议案》。该项议案获得同意票占比99.8793%，反对票占比0.0848%，弃权票占比0.0359%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091600038505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688314"],"gpt_icon":0},{"id":"2565546298","title":"每周股票复盘：康拓医疗（688314）拟每10股派2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565546298","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565546298?lang=zh_cn&edition=full","pubTime":"2025-09-07 07:45","pubTimestamp":1757202309,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，康拓医疗报收于37.58元，较上周的38.07元下跌1.29%。本周，康拓医疗9月3日盘中最高价报38.8元。本周关注点来自公司公告汇总：康拓医疗拟每10股派发现金红利2元（含税）。来自公司公告汇总：康拓医疗拟向参股公司提供不超过200万美元财务资助，年利率5%。公司公告汇总西安康拓医疗技术股份有限公司2025年第二次临时股东会会议将于2025年9月16日召开。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700001698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688314"],"gpt_icon":0},{"id":"2564444298","title":"股市必读：康拓医疗（688314）9月1日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2564444298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564444298?lang=zh_cn&edition=full","pubTime":"2025-09-02 03:26","pubTimestamp":1756754816,"startTime":"0","endTime":"0","summary":"截至2025年9月1日收盘，康拓医疗报收于37.55元，下跌1.37%，换手率2.15%，成交量1.75万手，成交额6604.07万元。来自机构调研要点：公司已顺利完成百余例全PEEK材料解决方案修复手术，推动4D生物活性板、PEEK螺钉等产品市场拓展。机构调研要点8月29日召开分析师电话会议。通过丰富产线、转移生产、提升运营效率等措施提高盈利能力，2025年上半年实现营业收入1,500.12万元，亏损558.15万元，较上年同期大幅减亏。2025年上半年公司境外实现营业收入1,775.51万元，同比增长9.46%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090200004181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688314"],"gpt_icon":0},{"id":"2563283431","title":"每周股票复盘：康拓医疗（688314）股东户数增14.97%，中报净利增12.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563283431","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563283431?lang=zh_cn&edition=full","pubTime":"2025-08-31 13:30","pubTimestamp":1756618227,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，康拓医疗报收于38.07元，较上周的39.77元下跌4.27%。本周，康拓医疗8月26日盘中最高价报41.8元。股本股东变化截至2025年6月30日，康拓医疗股东户数为5099户，较3月31日增加664户，增幅14.97%。业绩披露要点康拓医疗2025年中报显示，公司主营收入1.7亿元，同比上升11.07%；归母净利润5499.86万元，同比上升12.72%；扣非净利润5038.74万元，同比上升25.02%。截至报告期末，公司总股本81,239,172股，拟派发现金红利16,247,834.40元（含税），占同期归母净利润的29.54%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100004671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688314","BK0251"],"gpt_icon":0},{"id":"2563706880","title":"康拓医疗（688314）2025年中报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2563706880","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563706880?lang=zh_cn&edition=full","pubTime":"2025-08-30 06:16","pubTimestamp":1756505815,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期康拓医疗发布2025年中报。根据财报显示，康拓医疗营收净利润同比双双增长。截至本报告期末，公司营业总收入1.7亿元，同比上升11.07%，归母净利润5499.86万元，同比上升12.72%。按单季度数据看，第二季度营业总收入8782.54万元，同比上升5.28%，第二季度归母净利润3095.05万元，同比上升7.25%。本次财报公布的各项数据指标表现尚佳。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083000010610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688314"],"gpt_icon":0},{"id":"2562038833","title":"图解康拓医疗中报：第二季度单季净利润同比增长7.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562038833","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562038833?lang=zh_cn&edition=full","pubTime":"2025-08-28 18:12","pubTimestamp":1756375924,"startTime":"0","endTime":"0","summary":"证券之星消息，康拓医疗2025年中报显示，公司主营收入1.7亿元，同比上升11.07%；归母净利润5499.86万元，同比上升12.72%；扣非净利润5038.74万元，同比上升25.02%；其中2025年第二季度，公司单季度主营收入8782.54万元，同比上升5.28%；单季度归母净利润3095.05万元，同比上升7.25%；单季度扣非净利润2680.08万元，同比上升24.95%；负债率12.26%，投资收益-636.62万元，财务费用-75.16万元，毛利率78.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800035173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688314"],"gpt_icon":0},{"id":"2562825390","title":"康拓医疗(688314)6月30日股东户数0.51万户，较上期增加14.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562825390","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562825390?lang=zh_cn&edition=full","pubTime":"2025-08-28 17:27","pubTimestamp":1756373275,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康拓医疗披露，截至2025年6月30日公司股东户数为5099.0户，较3月31日增加664.0户，增幅为14.97%。在医疗器械行业个股中，康拓医疗股东户数低于行业平均水平，截至6月30日，医疗器械行业平均股东户数为2.21万户。从股价来看，2025年3月31日至2025年6月30日，康拓医疗区间涨幅为17.3%，在此期间股东户数增加664.0户，增幅为14.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800033187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688314","BK0251"],"gpt_icon":0},{"id":"2558314546","title":"康拓医疗涨5.05% 政策催化与资金回流推动上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2558314546","media":"智选洞察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558314546?lang=zh_cn&edition=full","pubTime":"2025-08-11 13:44","pubTimestamp":1754891091,"startTime":"0","endTime":"0","summary":"康拓医疗股价大幅上涨，截至13点44分，最新价报42.02元/股，涨幅达5.05%。资金博弈与政策共振催生股价波动康拓医疗近期净流出与政策催化及资金轮动密切相关。政策预期兑现引发资金分化，8月5日主力资金单日净流出800.9万元，但随后情绪修复，8月8日主力资金转为净流入2766.2万元。创新驱动与全球化战略构筑成长逻辑长期来看，康拓医疗的核心竞争力在于技术壁垒与战略布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811134459a6def531&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811134459a6def531&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0251","688314"],"gpt_icon":0},{"id":"2558835566","title":"医疗器械行业行业研究：脑机接口行业深度：政策+创新双轮驱动，商业化落地进入快车道","url":"https://stock-news.laohu8.com/highlight/detail?id=2558835566","media":"国金证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558835566?lang=zh_cn&edition=full","pubTime":"2025-08-10 12:06","pubTimestamp":1754798792,"startTime":"0","endTime":"0","summary":"投资逻辑国内政策叠加资本双重支持，行业迎来重大发展机遇。近年来国内政策端对脑机接口行业支持力度较高，支持性政策在产品注册、医保支付、行业标准等层面均有体现。1）在产品注册方面，国家药监局将配合相关部门出台基于脑机接口技术的医疗器械产品支持政策，脑机接口相关产品有望通过创新器械绿色通道实现更快注册审批。其中医疗健康领域仍是脑机接口应用最大的细分领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603222","688198","688273","688253","688351","600807","688581","688151","603309","688161","688393","688656","560260","688317","688767","688068","603205","688139","605369","688277","688029","688301","688016","688358","603987","688575","688468","688389","688607","600645","603014","688050","688271","688013","688366","688108","688606","688617","688217","159883","600055","688075","688576","688580","688314","688289","688212","688026","688085","688410","603387","600529","688298","688236","603658","688613","688067","600587","603880","603976","688114","688193","688338","688426","688677","688755"],"gpt_icon":0},{"id":"2557165655","title":"牙科医疗概念盘中拉升，乐普医疗涨9.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557165655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557165655?lang=zh_cn&edition=full","pubTime":"2025-08-08 10:15","pubTimestamp":1754619352,"startTime":"0","endTime":"0","summary":"08月08日，牙科医疗概念盘中拉升，截至10点15分，牙科医疗概念整体指数上涨0.50%，报1009.940点。从个股上来看，该概念的成分股中，乐普医疗涨9.97%，康拓医疗涨幅超过5%。从资金上来看，截止发稿，牙科医疗概念主力净流入为-3.34亿，其中乐普医疗受到资金热捧，主力净流入1.39亿；拉长时间线来看，该板块近20日主力资金净流入-19.66亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808101552a6d9e8c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808101552a6d9e8c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159891","BK0042","688314","BK0028","BK0188","BK0251","BK0114","BK0201","BK0113","300003","BK0196"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765734515109,"stockEarnings":[{"period":"1week","weight":-0.006},{"period":"1month","weight":-0.0611},{"period":"3month","weight":-0.1596},{"period":"6month","weight":0.0793},{"period":"1year","weight":0.0257},{"period":"ytd","weight":0.1108}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西安康拓医疗技术股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"5879人(较上一季度增加15.30%)","perCapita":"13818股","listingDate":"2021-05-18","address":"陕西省西安市长安区高新区毕原一路西段1451号","registeredCapital":"8123万元","survey":" 西安康拓医疗技术股份有限公司的主营业务是三类植入医疗器械产品研发、生产、销售。公司的主要产品是PEEK材料产品、钛材料产品、可吸收产品、脑引流装置、修补类产品、口腔种植、工具类。","listedPrice":17.34},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康拓医疗(688314)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康拓医疗(688314)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康拓医疗,688314,康拓医疗股票,康拓医疗股票老虎,康拓医疗股票老虎国际,康拓医疗行情,康拓医疗股票行情,康拓医疗股价,康拓医疗股市,康拓医疗股票价格,康拓医疗股票交易,康拓医疗股票购买,康拓医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康拓医疗(688314)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康拓医疗(688314)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}